Beckman Coulter, a prominent clinical diagnostics company, and Scopio Labs, a MedTech firm specialising in digital cell morphology solutions, have announced an expansion of their long-term partnership. The new agreement includes global distribution of Scopio’s Full-Field Bone Marrow Aspirate™ (FF-BMA) Application, which is CE-Marked for use with Scopio’s X100 and X100HT scanners.
Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term partnership to include a global distribution agreement of Scopio’s Full-Field Bone Marrow Aspirate™ (FF-BMA) Application. Scopio’s X100 / X100HT with FF-BMA Application are CE-Marked.
Eli Lilly and Company has announced plans for a $4.5 billion (£3.6 billion) facility that integrates pharmaceutical research and manufacturing. The Lilly Medicine Foundry, revealed on 2 October 2024, will aim to streamline drug discovery and production processes. This approach could significantly accelerate the journey from drug development through clinical trials to manufacturing.
The Intelligent Analyzer
AltoStar® Molecular Diagnostic Workflow
Dedicated kits for DiaSys respons® and BioMajesty® JCA-BM6010/C
Creat•eGFR•BUN•ePV•iMg•MCHC
MINI 96 96 Channel Portable Electronic Pipette
ADLM Association for • Diagnostics & • Laboratory Medicine | July 27 – 31, 2025, Chicago, USA, www.myadlm.org
April 11 – 15, 2025, Vienna, Austria, www.eccmid.org
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
